Theriva Biologics (TOVX) Preferred Stock Liabilities (2017 - 2024)
Theriva Biologics (TOVX) recorded Preferred Stock Liabilities of $1.75 million in Q2 2024, down 36.1% from $2.73 million a year earlier and down 36.1% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Preferred Stock Liabilities (2017 - 2024) Analysis & Trends
At the end of FY2023, Theriva Biologics reported Preferred Stock Liabilities of $2.73 million, unchanged from FY2022.
- Annual Preferred Stock Liabilities has a five-year compound annual growth rate of -26.0% (FY2018 to FY2023).
- Across earlier years, Preferred Stock Liabilities came in at $2.73 million in FY2022, $12.8 million in FY2020 (+2.0%) and $12.54 million in FY2019 (+2.0%).
- The Q2 2024 figure is the lowest quarterly Preferred Stock Liabilities in data going back to Q3 2017.
- Peak year-over-year performance for Preferred Stock Liabilities in the last five years was growth of 2.0% in Q4 2020, against a decline of 36.1% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.73 million (Q1 2024), $2.73 million (Q4 2023) and $2.73 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 2.73 Mn |
| Sep 30, 2022 | 2.73 Mn |
| Dec 31, 2020 | 12.80 Mn |
| Sep 30, 2020 | 12.73 Mn |
| Jun 30, 2020 | 12.67 Mn |
| Mar 31, 2020 | 12.61 Mn |
| Dec 31, 2019 | 12.54 Mn |
| Sep 30, 2019 | 12.48 Mn |
| Jun 30, 2019 | 12.42 Mn |
| Mar 31, 2019 | 12.36 Mn |
| Dec 31, 2018 | 12.30 Mn |
| Sep 30, 2018 | 12.23 Mn |
| Jun 30, 2018 | 12.17 Mn |
| Mar 31, 2018 | 12.11 Mn |
API Access
Theriva Biologics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();